What is Livagen? Mechanism, Benefits, Dosage
Summary
Livagen is a tetrapeptide bioregulator (KEDA: Lys–Glu–Asp–Ala) investigated for epigenetic actions — specifically, opening condensed chromatin to restore youthful gene expression in aged cells.
Substance Properties
What is Livagen?
Livagen is a short 'bioregulatory' peptide of four amino acids (Lys–Glu–Asp–Ala / KEDA) studied primarily for its ability to relax age-condensed chromatin and normalize gene activity in aged cells.
Epigenetic actions: Chromatin decondensation
In experiments on human lymphocytes, Livagen 'deheterochromatinized' DNA and reactivated ribosomal genes. In other models, it regulated digestive enzymes and protected endogenous enkephalins by inhibiting their breakdown — without binding opioid receptors.
Hepatoprotective and immunomodulatory properties
In animal models, Livagen exhibited hepatoprotective and immunomodulatory actions. Chromatin decondensation in lymphocytes suggests improved protein synthesis and restoration of normal gene expression rates.
Enkephalinase inhibition
A unique property of Livagen is potent inhibition of enzymes that degrade enkephalins (enkephalinases), extending endogenous enkephalin tone associated with stress relief and analgesia. This is achieved without opioid receptor agonism.
Related Guides
Frequently Asked Questions (FAQ)
How does Livagen differ from Epithalon?
Epithalon targets telomerase and the pineal gland, while Livagen focuses on chromatin decondensation and immunomodulation. They serve different goals in the anti-aging spectrum.
References & Studies
Disclaimer
This article is exclusively educational for researchers. It does not constitute medical advice.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer